Epsymed ASBL

1.0 FTE

Epsymed reported revenue of €6.76m for the 2025 financial year (annual accounts filed with the NBB on 29 Jul 2026), with 1 full-time equivalent.

By total assets for 2025, Epsymed ranks among the 500 largest of the 2,910 companies in its sector (NACE 8210) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0430.054.052 · VAT BE0430054052
1180 Uccle
active in Office administrative and support activities (NACE 82100)
operating since 25 Sep 1984 (≈ 42 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Epsymed shows with a free account.

See the score
Profile
ASBL Micro · 1.0 FTE since 1984
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Revenue€6.76m
Net result41,913 €
Equity€1.16m
Cash€1.15m
EBITDA47,579 €
Total assets€1.17m
Headcount (avg FTE)1.0
The line marks its sector median: 39.0% (348 companies).

Change 2022 → 2025: Equity -17 % Total assets -16 %

Accounts of the company itself (not consolidated).

The full file covers 4 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Epsymed's annual accounts

2025202420232022
Revenue€6.76m
Net result41,913 €
Equity€1.16m
Cash€1.15m
EBITDA47,579 €
Total assets€1.17m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 29 Jul 2026
  • Year ended 31 Dec 2024filed on 30 Jul 2025
  • Year ended 31 Dec 2023filed on 29 May 2024
  • Year ended 31 Dec 2022filed on 23 May 2024

Epsymed's financial analysis

Management and control of Epsymed

8 active director(s) in the register.

and 2 more

Epsymed's shareholders and holdings →

Epsymed's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0430.054.052
VAT number
BE0430054052
Peppol
Registered · 0208:0430054052 · as of 10 Nov 2026
Legal form
ASBL
Incorporated
25 Sep 1984
Registered office
1180 Uccle
Size
Micro · 1.0 FTE
Latest accounts
2025 · filed on 29 Jul 2026
Activity
Office administrative and support activities (NACE 82100)

Epsymed (ASBL) has been based in Uccle since 1984, active in: office administrative and support activities. For 2025, it reports revenue of €6.76m, a net profit of 41,913 € and equity of €1.16m. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 98.7%, above the median of its sector (39.0%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Epsymed

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Epsymed

What is the revenue of Epsymed?

According to the 2025 annual accounts filed with the NBB, the revenue of Epsymed amounts to 6,764,953 €.

What is the VAT number of Epsymed?

In Belgium, the VAT number is the company number prefixed with BE: BE0430054052 for Epsymed, if the company is VAT-registered. Its company number (CBE) is 0430.054.052.

Where is the registered office of Epsymed?

According to the CBE register, the registered office of Epsymed is in 1180 Uccle.

What is the equity of Epsymed?

At the close of the 2025 financial year, the equity of Epsymed amounts to 1,155,806 €, a solvency of 98.7% of total assets.

How many people work at Epsymed?

1.0 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Epsymed?

The register lists 8 active mandates at Epsymed. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Epsymed within its sector?

By total assets for 2025, Epsymed ranks among the 500 largest of the 2,910 companies in its sector (NACE 8210) in Belgium that filed accounts for that financial year.

Idonis

The full file of Epsymed

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 11 Aug 2026

No credit card, no commitment.

What each plan unlocks →